KeyBanc raises Huntsman stock price target on merger synergies

KeyBanc raised its price target for Huntsman (NYSE:HUN) to $13, citing merger synergies with OLN and better-than-expected Q3 results. The stock trades at $9.45, with a Fair Value of $13.16. Huntsman reported mixed Q3 earnings, missing EPS estimates but exceeding revenue forecasts. Jefferies initiated coverage with a Buy rating and $12 target. The company faces rising input costs but aims for $100M EBITDA improvement in 2026.

Original reporting
Published Nov 9, 2026, 10:48 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 10:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HUN
Bullish
high confidence
Mentioned
$HUN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUNBullishMed
01

Why it matters

The price target increase reflects a belief that the merger will add $6 per share in value, potentially driving the stock toward the new target.

02

Market read

Analyst upgrade and merger synergies provide a fresh catalyst for Huntsman, offering a short‑term trade idea.

03

What to watch

Rising input and energy costs could offset expected margin improvements.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

KeyBanc's upgrade follows Huntsman's mixed Q3 earnings and pending merger with OLN, which is expected to close in 2‑3 months.

Company-level read

Ticker impact

$HUNBullishHigh confidence
Context

KeyBanc raised its price target on Huntsman to $13, citing merger synergies with OLN and better-than-expected Q3 results.

Expected impact

likely upward as investors price in the $6 per share synergy value.

Evidence & confidence

The new target is $1 above current price and reflects a concrete NPV synergy estimate.

Market effects

Potentially lifts other specialty chemicals peers as merger may set a valuation benchmark.

U.S. specialty chemicals sector may see modest re‑rating.

Limited to investors tracking M&A in the chemicals space.

Counterpoint

Synergy assumptions could be optimistic; integration risk may temper upside.

Key entities

  • Huntsman Corp.

    Specialty chemicals producer (NYSE:HUN).

  • OLN

    Merger partner of Huntsman.

Related articles

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.